women-in-science.


Wednesday, September 2 | 7:25 am

Women in Science Panel Discussion with Continental Breakfast

The PEGS team is excited to bring back its Women in Science program to honor and celebrate women that are changing the landscape of healthcare and biotech.

This morning session will create a forum to share thought-provoking questions, inspiring stories, practical advice, and networking opportunities with influencers in the field.

 

Moderator:
Rochard_LucieLucie Rochard, PhD, Liaison, Scientific & Entrepreneurial Initiatives; Director, Innovation Services, Massachusetts Biotechnology Council


Panelists:
Nora MinevaNora Mineva, PhD, CSO, Adecto Pharmaceuticals


Liu_TinaTina Liu, MBA, Co-Founder and CEO, Ally Therapeutics


Chadwich_JenniferJennifer Chadwich, PhD, Vice President, Biologic Development, BioAnalytix, Inc.


Topics to be covered include:

  • Career development
  • Mentorship 
  • Creating positive work cultures and environments
  • Combating impostor syndrome

After the panel, continue the discussion during a speed networking session in the exhibit hall during the morning coffee break

If you would like to participate as a panelist, please contact:

Kaitlyn Barago
Project Manager, Production Initiatives
kbarago@healthtech.com
781-247-6282

Speaker Biographies:

Jennifer Chadwich, PhD, Vice President, Biologic Development, BioAnalytix, Inc.

Dr. Jennifer Chadwick is an innovative leader with >15 years professional academic and industrial experience in biotechnology, pharmaceutics and life sciences. She is Vice President of Biologic Development at BioAnalytix and formerly tenured Professor and Louise Byrd Graduate Educator in the Department of Pharmaceutical Chemistry at the University of Kansas. Prof. Chadwick transitioned to industry after founding a company to commercialize technology developed in her academic lab and serving as CSO and Director. She is a recognized expert in analytical development, formulation and stability assessment of biologics and has extensive background in biologic drug discovery, translational research and early/late stage development of complex, emerging therapeutics applied to diverse clinical indications. Her corporate responsibilities have included corporate/scientific enterprise strategy, product development, business development, project management, team building and alliance management, IP portfolio management and early-stage fundraising. Dr. Chadwick has a significant history and ongoing commitment of influential leadership in professional communities and strong engagement in mentoring and career development. She serves as Associate Director, CASSS; Visiting Scholar, Department of Chemistry and Chemical Biology, Northeastern University; Editorial Advisory Board member, Journal of Pharmaceutical Sciences and Scientific Reports; MassBio Steering Committee for Academic-Industry Relations; Mentor for MassCONNECT; and Co-chair of Mentors, Advisors, Peers and Sponsorship, WIB, Boston Chapter.

Tina Liu, MBA, Co-Founder and CEO, Ally Therapeutics

Tina serves as co-founder/CEO of Ally Therapeutics, an innovative company dedicated to solving the immune response barriers for gene therapy. She spun the company out of the Wyss Institute at Harvard, where she had supported the foundational research as an Entrepreneur-in-Residence. Prior, Tina was a private equity investor at TPG Capital, where she evaluated potential investments $1Bn+ in size across commercial pharma and other sectors of the healthcare industry. Before that, Tina was an investment banker at Morgan Stanley, where she advised healthcare companies on key transactions including mergers and acquisitions, equity and debt financings, and other strategic alternatives. Tina received her MBA with Distinction from Harvard Business School and her BA, magna cum laude, from Harvard College.    

Nora Mineva, PhD, CSO, Adecto Pharmaceuticals

Dr. Nora Mineva is the Chief Scientific Officer and a co-founder of Adecto Pharmaceuticals, a start-up developing the first targeted treatment against ADAM8-positive cancers and a companion diagnostic to identify patients who can benefit from it, with a focus on triple-negative breast cancer as the first indication. She holds a Ph.D. in Pathology and Laboratory Medicine from Boston University School of Medicine and a B.A./M.A. in Biology from Clark University. Dr. Mineva is involved in company management, business development, investor relations, and fundraising efforts in addition to therapeutic and diagnostic development. She is a graduate of the NIH I-Corps Business Training Program and MassBio’s MassConnect Entrepreneur Mentorship Program. 

Lucie Rochard, PhD, Liaison, Scientific & Entrepreneurial Initiatives; Director, Innovation Services, Massachusetts Biotechnology Council

Lucie has over ten years of experience in conducting biomedical research. She trained in Rennes, France, at the National Center for Research (CNRS) and the National Institute of Health and Medical Research (INSERM). After graduating with her Ph.D., Lucie moved to the US to complete a post-doctoral fellowship at the Massachusetts General Hospital and Shriners Hospital (joint appointment) in Boston, Massachusetts. Committed to foster alliances between Academia and Industry, to facilitate the transfer of technology for the benefit of patients, Lucie joined the largest trade association for the life Sciences, MassBio in 2017 and is Director Innovation Services. Within MassBio, in the Innovation Services team, Lucie created and now leads the Academic outreach and Engagement initiatives. Her mission is to leverage MassBio’s community of members and experts with the goal to facilitate company creation and strategic alliances within academic institutions. Over the last two years, Lucie has built several working groups convening leaders from academia and industry, as well as mentoring programs for academic scientists and joined several advisory boards to foster entrepreneurship beyond the Boston region.

Cambridge Healthtech Institute is proud to offer programming that honors and celebrates the advancement of diversity in the life sciences. We recognize that barriers preventing women from fully participating in the sciences are not just barriers to equality, but also critically deter scientific advancement worldwide. Our Women in Science programming invites the entire scientific community to discuss these barriers, as we believe that all voices are necessary and welcome. We hope that you will mark your calendar to join us for this important discussion!*


*The Women in Science Panel Discussion is open to conference attendees. The Women in Science Speed Networking Session is open to all conference and exhibit hall and plenary keynote pass attendees.


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag

eLearning

View By: